RAH
Societal Cdmo, Inc.
A contract development and manufacturing organization that helps pharmaceutical and biotech companies turn drug ideas into real-world medicines — from early formulation to commercial-scale production. It has a specialty in controlled substances, and its Georgia and San Diego facilities now make Schedule 1 psychedelic compounds for clinical trials. Born as Recro Pharma in 2007, it rebranded in 2022 under the motto "Bringing Science to Society," a name meant to reflect its mission of getting new therapies to patients.
CUSIP: 75629F109HealthcareUS1 holder